JHCP
GILD icon

Jackson Hole Capital Partners’s Gilead Sciences GILD Stock Holding History

Jackson Hole Capital Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.64M Buy
33,305
+70
+0.2% +$9.8K 0.77% 37
2025
Q4 		$4.08M Sell
33,235
-3
-0% -$365 0.7% 37
2025
Q3 		$3.69M Sell
33,238
-1,458
-4% -$166K 0.63% 46
2025
Q2 		$3.85M Buy
34,696
+603
+2% +$64.2K 0.71% 39
2025
Q1 		$3.82M Sell
34,093
-481
-1% -$49.6K 0.76% 34
2024
Q4 		$3.19M Buy
34,574
+2,201
+7% +$198K 0.65% 42
2024
Q3 		$2.71M Buy
32,373
+2,079
+7% +$159K 0.57% 52
2024
Q2 		$2.08M Buy
30,294
+7,198
+31% +$480K 0.45% 65
2024
Q1 		$1.69M Buy
23,096
+3,504
+18% +$269K 0.38% 75
2023
Q4 		$1.59M Buy
19,592
+1,241
+7% +$96.6K 0.4% 66
2023
Q3 		$1.38M Buy
18,351
+395
+2% +$30.4K 0.4% 68
2023
Q2 		$1.38M Sell
17,956
-598
-3% -$47.7K 0.38% 68
2023
Q1 		$1.53M Buy
18,554
+117
+0.6% +$9.69K 0.4% 65
2022
Q4 		$1.58M Sell
18,437
-210
-1% -$16.6K 0.47% 59
2022
Q3 		$1.15M Buy
18,647
+227
+1% +$14.3K 0.35% 75
2022
Q2 		$1.14M Buy
18,420
+1,308
+8% +$81K 0.36% 72
2022
Q1 		$1.02M Buy
17,112
+2,499
+17% +$160K 0.29% 85
2021
Q4 		$1.06M Buy
14,613
+1,852
+15% +$128K 0.33% 75
2021
Q3 		$891K Buy
12,761
+1,791
+16% +$126K 0.29% 85
2021
Q2 		$755K Buy
10,970
+47
+0.4% +$3.14K 0.26% 87
2021
Q1 		$706K Buy
10,923
+1,419
+15% +$91.5K 0.29% 76
2020
Q4 		$554K Buy
9,504
+126
+1% +$7.6K 0.25% 80
2020
Q3 		$593K Buy
9,378
+497
+6% +$34.5K 0.31% 69
2020
Q2 		$683K Buy
8,881
+188
+2% +$14.4K 0.42% 65
2020
Q1 		$650K Hold
8,693
– – 0.48% 55
2019
Q4 		$565K Hold
8,693
– – 0.31% 81
2019
Q3 		$551K Buy
8,693
+1,274
+17% +$83.3K 0.31% 79
2019
Q2 		$501K Buy
7,419
+1,622
+28% +$107K 0.31% 83
2019
Q1 		$377K Buy
5,797
+700
+14% +$46.5K 0.33% 92
2018
Q4 		$319K Buy
+5,097
New +$356K 0.34% 92

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Jackson Hole Capital Partners's GILD Position: Q1 2026 in Review

Jackson Hole Capital Partners increased its Gilead Sciences (GILD) stake by 0.21% in Q1 2026, buying an estimated $9.8K and bringing the position to 33,305 shares worth $4.64M. The position accounts for 0.77% of the portfolio, ranked #37.

Jackson Hole Capital Partners first reported a position in GILD in Q4 2018 and has held it in 30 quarters since. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Jackson Hole Capital Partners held 33,305 shares of Gilead Sciences worth $4.64M as of Q1 2026.
  • Jackson Hole Capital Partners bought 70 Gilead Sciences shares in Q1 2026, an estimated $9.8K.
  • Gilead Sciences made up 0.77% of Jackson Hole Capital Partners's portfolio in Q1 2026, its #37 holding.
  • Jackson Hole Capital Partners first reported a position in Gilead Sciences in Q4 2018 and has held it in 30 quarters since.
  • 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Jackson Hole Capital Partners's 13F filing for Q1 2026, filed 8 May 2026.